1. Bieg, Matthias, Moskalev, Evgeny A, Will, Rainer, Giannini, Caterina, Haller, Florian. 2021. Gene Expression in Solitary Fibrous Tumors (SFTs) Correlates with Anatomic Localization and NAB2-STAT6 Gene Fusion Variants. In The American journal of pathology, 191, 602-617. doi:10.1016/j.ajpath.2020.12.015. https://pubmed.ncbi.nlm.nih.gov/33497701/
2. Hatami, Mahsa, Salmani, Tayyebali, Arsang-Jang, Shahram, Sayad, Arezou, Taheri, Mohammad. 2017. STAT5a and STAT6 gene expression levels in multiple sclerosis patients. In Cytokine, 106, 108-113. doi:10.1016/j.cyto.2017.10.022. https://pubmed.ncbi.nlm.nih.gov/29126764/
3. Li, Yi, Mondaza-Hernandez, Jose L, Moura, David S, Hayenga, Heather N, Bleris, Leonidas. 2024. STAT6-targeting antisense oligonucleotides against solitary fibrous tumor. In Molecular therapy. Nucleic acids, 35, 102154. doi:10.1016/j.omtn.2024.102154. https://pubmed.ncbi.nlm.nih.gov/38511173/
4. Verhoeven, Yannick, Tilborghs, Sam, Jacobs, Julie, Lardon, Filip, van Dam, Peter A. 2019. The potential and controversy of targeting STAT family members in cancer. In Seminars in cancer biology, 60, 41-56. doi:10.1016/j.semcancer.2019.10.002. https://pubmed.ncbi.nlm.nih.gov/31605750/
5. Benoit, Alexandre, Abraham, Madelyn J, Li, Sheena, Johnson, Nathalie A, Mann, Koren K. 2024. STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment. In International journal of hematology, 119, 275-290. doi:10.1007/s12185-023-03692-x. https://pubmed.ncbi.nlm.nih.gov/38285120/